Cannara Biotech (TSXV:LOVE) EV-to-Revenue : 1.60 (As of May. 23, 2024)

View and export this data going back to 2019. Start your Free Trial

What is Cannara Biotech EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Cannara Biotech's enterprise value is C$117.43 Mil. Cannara Biotech's Revenue for the trailing twelve months (TTM) ended in Feb. 2024 was C$73.34 Mil. Therefore, Cannara Biotech's EV-to-Revenue for today is 1.60.

The historical rank and industry rank for Cannara Biotech's EV-to-Revenue or its related term are showing as below:

TSXV:LOVE' s EV-to-Revenue Range Over the Past 10 Years
Min: 1.56 Med: 7.2 Max: 67.08
Current: 1.6

During the past 6 years, the highest EV-to-Revenue of Cannara Biotech was 67.08. The lowest was 1.56. And the median was 7.20.

TSXV:LOVE's EV-to-Revenue is ranked better than
65.98% of 1026 companies
in the Drug Manufacturers industry
Industry Median: 2.325 vs TSXV:LOVE: 1.60

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-23), Cannara Biotech's stock price is C$0.79. Cannara Biotech's Revenue per Share for the trailing twelve months (TTM) ended in Feb. 2024 was C$0.82. Therefore, Cannara Biotech's PS Ratio for today is 0.97.

Cannara Biotech EV-to-Revenue Historical Data

The historical data trend for Cannara Biotech's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cannara Biotech EV-to-Revenue Chart

Cannara Biotech Annual Data

Trend

Aug18

Aug19

Aug20

Aug21

Aug22

Aug23

EV-to-Revenue

Get a 7-Day Free Trial

47.23

29.50

9.50

4.32

2.30

Cannara Biotech Quarterly Data
	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
EV-to-Revenue	Get a 7-Day Free Trial															2.55	2.74	2.30	1.78	1.83

Competitive Comparison of Cannara Biotech's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Cannara Biotech's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cannara Biotech's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cannara Biotech's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Cannara Biotech's EV-to-Revenue falls into.

Cannara Biotech EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Cannara Biotech's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	117.434	/	73.337
	=	1.60

Cannara Biotech's current Enterprise Value is C$117.43 Mil.
Cannara Biotech's Revenue for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$73.34 Mil.

Cannara Biotech (TSXV:LOVE) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Cannara Biotech's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	0.79	/	0.817
	=	0.97

Cannara Biotech's share price for today is C$0.79.
Cannara Biotech's Revenue per Share for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.82.

Cannara Biotech EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Cannara Biotech's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Cannara Biotech (TSXV:LOVE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cannara Biotech Inc (TSXV:LOVE) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

LOVFF:USA 8CB0:Germany

Address

1055 West Georgia Street, Suite 2050, Vancouver, BC, CAN, V6E 3P3

Website

http://www.cannara.ca

Cannara Biotech Inc is a vertically integrated producer of premium-grade cannabis and cannabis-derivative products for Canadian markets. The company owns two mega Quebec-based facilities. The company operates in in two segments; Indoor cannabis operations segment which includes the cultivation, processing and sale of dried cannabis and cannabis derivatives for the Canadian market and the Real estate operations segment related to the Farnham and Valleyfield building. Majority of the revenue for the company is generated from its Cannabis operations segment. .

Executives